Difference between revisions of "Fouladi M, et al. J. Clin. Oncol. (2011) cited as Ref 575 in DOI: 10.1038/s41392-020-0110-5 (Q9838)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 29, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study, #quickstatements; #temporary_batch_1590010982689) |
||
| Property / title | |||
| + | Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study (English) | ||
| Property / title: Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study (English) / rank | |||
| + | Normal rank | ||
Revision as of 22:04, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Fouladi M, et al. J. Clin. Oncol. (2011) cited as Ref 575 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Fouladi M
0 references
2011
0 references
J. Clin. Oncol.
0 references
29
0 references
Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study (English)
0 references
